Skip to Content

Tristar Wellness Solutions Inc TWSI

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TWSI is trading at a 75% premium.
Price
$0.00
Fair Value
$4.15
Uncertainty
Extreme
1-Star Price
$8.53
5-Star Price
$4.53
Economic Moat
Bllg
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TWSI is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.01
Bid/Ask
$0.00 / $0.05
Market Cap
$60,193.12
Volume/Avg
10,004 / 4,645

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Tristar Wellness Solutions Inc develops wellness products. It is engaged in the development, marketing and sale of HemCon's wound care products. The wound care treatment products focused on superior hemostasis and infection control technology targeting a wide range of professional medical such as interventional cardiology, surgery, dialysis, post-procedure recovery, trauma, military and first responder’s applications. Its products are designed to improve health advocacy and medical outcomes. Geographically operations are functioned through the region of United States.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees

Valuation

Metric
TWSI
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
TWSI
Quick Ratio
0.05
Current Ratio
0.10
Interest Coverage
−1.53
Quick Ratio
TWSI

Profitability

Metric
TWSI
Return on Assets (Normalized)
−196.42%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
TWSI
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
QtxjnlbrrNbb$81.2 Bil
Merck KGaA ADR
MKKGY
ZwdrtwvkJwwsg$71.8 Bil
Haleon PLC ADR
HLN
RvbbtkqWzx$39.4 Bil
Teva Pharmaceutical Industries Ltd ADR
TEVA
LdkycvndScxq$19.7 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
LblkbtvgVzv$13.5 Bil
Viatris Inc
VTRS
TvqhmbwlXqgd$13.1 Bil
Catalent Inc
CTLT
SpmshjxjfWkbqbg$10.5 Bil
Perrigo Co PLC
PRGO
SdmhgnyyqCbt$3.7 Bil
Prestige Consumer Healthcare Inc
PBH
CwtjtblkSddrxf$3.5 Bil
Curaleaf Holdings Inc
CURLF
QxpvnkyHtp$3.1 Bil

Sponsor Center